Most importantly, increased circulating levels of these soluble molecules are strongly associated with progression of DR [25,26,27], thus raising the question of whether and how ADAM17 may contribute to DR pathogenesis especially to diabetes-induced retinal microvascular injury. The gene discussed is ADAM17; the disease is diabetes mellitus.